Nanlin Li

789 total citations
26 papers, 573 citations indexed

About

Nanlin Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nanlin Li has authored 26 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nanlin Li's work include Ubiquitin and proteasome pathways (4 papers), BRCA gene mutations in cancer (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Nanlin Li is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), BRCA gene mutations in cancer (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Nanlin Li collaborates with scholars based in China and United States. Nanlin Li's co-authors include Wenpeng Dong, Haining Zhen, Richard D. Ye, Gang Zhao, Dakuan Gao, Xiangwei Kong, Zhi‐Ren Rao, Xiang Zhang, Rong Cao and Junliang Han and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Psychology and Journal of Vascular Surgery.

In The Last Decade

Nanlin Li

25 papers receiving 568 citations

Peers

Nanlin Li
Yu Hou China
Wenliang Zha China
Shanying Huang China
Ya‐Ge Jin China
Jie Xiao China
Bowen Dong China
Pan Gao China
Peng Guan China
Yu Hou China
Nanlin Li
Citations per year, relative to Nanlin Li Nanlin Li (= 1×) peers Yu Hou

Countries citing papers authored by Nanlin Li

Since Specialization
Citations

This map shows the geographic impact of Nanlin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanlin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanlin Li more than expected).

Fields of papers citing papers by Nanlin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanlin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanlin Li. The network helps show where Nanlin Li may publish in the future.

Co-authorship network of co-authors of Nanlin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Nanlin Li. A scholar is included among the top collaborators of Nanlin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanlin Li. Nanlin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jixin, et al.. (2025). Drug treatment of breast cancer brain metastases: progress and challenges. Discover Oncology. 16(1). 1025–1025. 1 indexed citations
2.
Zhang, Juliang, Meiling Huang, Jingjing Xiao, et al.. (2023). Design, strategies, and therapeutics in nanoparticle-based siRNA delivery systems for breast cancer. Journal of Materials Chemistry B. 11(34). 8096–8116. 8 indexed citations
3.
4.
Huang, Meiling, et al.. (2022). Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. World Journal of Clinical Cases. 10(32). 11690–11701. 11 indexed citations
5.
Wang, Yijia, et al.. (2022). COVID-induced 3  weeks’ treatment delay may exacerbate breast cancer patient’s psychological symptoms. Frontiers in Psychology. 13. 1003016–1003016. 3 indexed citations
6.
7.
Ling, Rui, et al.. (2020). Quadruple negative breast cancer. Breast Cancer. 27(4). 527–533. 22 indexed citations
8.
Wang, Ting, Juliang Zhang, Jingjing Xiao, et al.. (2019). Mutational analysis of BRCA1 and BRCA2 in northwest Chinese breast cancer patients. Translational Cancer Research. 8(5). 1845–1852. 1 indexed citations
9.
Wang, Ting, Juliang Zhang, Jingjing Xiao, et al.. (2019). Mutational analysis of BRCA1 and BRCA2 in northwest Chinese breast cancer patients. Translational Cancer Research. 8(5). 1845–1852. 3 indexed citations
10.
11.
Wang, Hui, Nanlin Li, Haifeng Jin, et al.. (2013). Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma. Phytomedicine. 20(11). 985–991. 36 indexed citations
12.
Wang, Hui, Yongping Li, Jianghao Chen, et al.. (2013). Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma. Tumor Biology. 34(3). 1635–1639. 39 indexed citations
13.
14.
Wang, Tao, Nan You, Kaishan Tao, et al.. (2012). Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hepatocytes. Development Growth & Differentiation. 54(5). 605–617. 26 indexed citations
15.
Shi, Hai Yun, Nanlin Li, Shujun Li, et al.. (2010). Expression of NDRG2 in esophageal squamous cell carcinoma. Cancer Science. 101(5). 1292–1299. 35 indexed citations
16.
Shi, Hai Yun, Yi Zhou, Heliang Liu, et al.. (2010). Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. BMC Cancer. 10(1). 477–477. 20 indexed citations
17.
Li, Fanfan, Yu Gu, Wenpeng Dong, et al.. (2010). Cell death‐inducing DFF45‐like effector, a lipid droplet‐associated protein, might be involved in the differentiation of human adipocytes. FEBS Journal. 277(20). 4173–4183. 36 indexed citations
18.
Ye, Richard D., Nanlin Li, Junliang Han, et al.. (2009). Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neuroscience Research. 64(3). 306–310. 110 indexed citations
19.
Yuan, Shifang, Changhong Shi, Wei Han, et al.. (2009). Effective anti-tumor responses induced by recombinant bacillus Calmette–Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF. European Journal of Cancer Prevention. 18(5). 416–423. 10 indexed citations
20.
Dong, Wenpeng, et al.. (2008). Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. Journal of Vascular Surgery. 48(3). 709–714. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Hou Breakdown of academic impact, for papers by Wenliang Zha Breakdown of academic impact, for papers by Shanying Huang Breakdown of academic impact, for papers by Ya‐Ge Jin Breakdown of academic impact, for papers by Jie Xiao Breakdown of academic impact, for papers by Bowen Dong Breakdown of academic impact, for papers by Pan Gao Breakdown of academic impact, for papers by Peng Guan
Rankless by CCL
2026